AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

SOLV · NYSE · Medical - Instruments & Supplies

Solventum (SOLV)

Makes wound-care, surgical, and dental products alongside healthcare workflow software.

$88.75

After hours−0.03 (−0.04%)

At close$88.79(−0.06%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	2,074	2,036	2,016	2,081	2,082	2,075	2,070	2,161	2,096	1,998	2,007	2,209
Cost of revenue	865	878	844	944	917	956	956	986	919	1,013	910	923
Gross profit	1,209	1,158	1,172	1,137	1,165	1,119	1,114	1,175	1,177	985	1,097	1,286
	705	752	791	893	890	983	962	961	1,040	−693	1,016	1,105
Research & development	180	190	195	192	189	199	193	189	183	176	189	178
	525	562	596	701	701	784	769	772	780	759	827	927
General & administrative	0	0	0	0	0	0	0	0	0	0	827	0
Other expenses	0	0	0	0	0	0	0	0	77	−1,628	0	0
Operating income	504	406	381	244	275	136	152	214	137	1,678	81	181
	−4	−15	−52	−148	−108	−123	−114	−111	1,377	−1,620	−65	−73
Interest expense	0	0	39	114	107	107	104	103	89	51	62	64
Other non-operating income	4	15	13	34	1	16	10	8	−1,466	1,569	3	9
Income before tax	500	391	329	96	167	13	38	103	1,514	58	16	108
Income tax expense	40	119	92	7	45	−17	−99	13	248	−5	3	15
Net income from continuing operations	460	272	237	89	122	30	137	90	1,266	63	13	93
Other adjustments	0	0	0	0	0	1	0	0	0	0	0	−1
Net income	460	272	237	89	122	31	137	90	1,266	63	13	92
EPS, basic	$2.66	$1.57	$1.37	$0.51	$0.70	$0.18	$0.79	$0.52	$7.26	$0.36	$0.07	$0.53
EPS, diluted	$2.66	$1.57	$1.37	$0.51	$0.70	$0.18	$0.78	$0.51	$7.22	$0.37	$0.07	$0.53
Weighted average shares, basic	173	173	173	173	173	173	174	174	174	174	174	174
Weighted average shares, diluted	173	173	173	174	174	175	175	175	175	175	176	174
EBITDA	644	530	507	343	407	270	271	328	1,724	489	213	172
Depreciation & amortization	144	139	139	133	133	150	129	122	121	380	135	0
EBIT	500	391	368	210	274	120	142	206	1,603	109	78	172